Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021
Hancock Jaffe Laboratories, a developer of medical devices, will host a corporate update conference call on September 21, 2021, at 4:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Hancock Jaffe Laboratories, a developer of medical devices, will host a corporate update conference call on September 21, 2021, at 4:30 p.m. ET. Management will discuss the ongoing development of VenoValve and other corporate initiatives. The call will be led by Robert Berman, CEO, and Dr. Marc Glickman, CMO. Interested parties can participate by calling (877) 407-9708 (domestic) or (201) 689-8259 (international). The live webcast will be available on Hancock Jaffe's Investors section of their website, archived for 90 days.
Details
News Market Reaction – HJLI
The recorded move for HJLI in the trading session of this news was +5.13%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference call with live video webcast to be held on Tuesday, September 21st at 4:30 p.m. ET
IRVINE, CA / ACCESSWIRE / September 15, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a developer of medical devices that restore cardiac and vascular health, today announced that Hancock Jaffe management will host a corporate update conference call with a live video webcast on Tuesday, September 21, 2021 at 4:30 p.m. ET.
As part of the call, management will discuss VenoValve's continued development and other ongoing corporate initiatives. The call will be led by Robert Berman, Chief Executive Officer of Hancock Jaffe, who will be joined by Dr. Marc Glickman, Chief Medical Officer of Hancock Jaffe. Interested participants and investors may access the conference call by dialing (877) 407-9708 (domestic) or (201) 689-8259 (international). The live webcast will be accessible on the IR Calendar page of the Investors section of the Hancock Jaffe website, www.hancockjaffe.com, and will be archived for 90 days.
About Hancock Jaffe Laboratories, Inc.
Hancock Jaffe Laboratories (NASDAQ:HJLI) specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValve®, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraft®, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
HJLI@jtcir.com
(833) 475-8247
MEDIA CONTACT:
Michelle McAdam, Chronic Communications, Inc.
michelle@chronic-comm.com
(310) 902-1274
SOURCE: Hancock Jaffe Laboratories, Inc.
View source version on accesswire.com:
https://www.accesswire.com/664103/Hancock-Jaffe-to-Host-Corporate-Update-Conference-Call-and-Webcast-on-September-21-2021
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.